(Q77708314)
Statements
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial (English)
P Keck
A Buffenstein
J Ferguson
J Feighner
W Jaffe
E P Harrigan
1 November 1998